Robert Freedman
Concepts (532)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizophrenia | 72 | 2020 | 429 | 9.380 |
Why?
| Choline | 12 | 2024 | 117 | 5.020 |
Why?
| Evoked Potentials, Auditory | 39 | 2024 | 178 | 3.870 |
Why?
| Receptors, Nicotinic | 37 | 2013 | 322 | 3.650 |
Why?
| Nicotinic Agonists | 15 | 2016 | 125 | 3.510 |
Why?
| Brain | 35 | 2021 | 2618 | 2.690 |
Why?
| alpha7 Nicotinic Acetylcholine Receptor | 24 | 2016 | 101 | 2.440 |
Why?
| Hippocampus | 31 | 2013 | 795 | 2.310 |
Why?
| Psychotic Disorders | 9 | 2021 | 153 | 2.080 |
Why?
| Prenatal Exposure Delayed Effects | 8 | 2021 | 551 | 2.010 |
Why?
| Hot Flashes | 7 | 2014 | 81 | 1.980 |
Why?
| Neural Inhibition | 17 | 2013 | 152 | 1.890 |
Why?
| Psychiatry | 5 | 2018 | 173 | 1.860 |
Why?
| Sensory Gating | 8 | 2020 | 44 | 1.850 |
Why?
| Benzylidene Compounds | 8 | 2013 | 18 | 1.800 |
Why?
| Schizophrenic Psychology | 19 | 2015 | 93 | 1.790 |
Why?
| Periodicals as Topic | 5 | 2018 | 206 | 1.730 |
Why?
| Folic Acid | 4 | 2024 | 183 | 1.640 |
Why?
| Pregnancy Complications, Infectious | 4 | 2021 | 335 | 1.630 |
Why?
| Nicotine | 17 | 2013 | 303 | 1.550 |
Why?
| Fetal Development | 9 | 2024 | 283 | 1.540 |
Why?
| Pyridines | 8 | 2013 | 469 | 1.390 |
Why?
| Antidepressive Agents | 3 | 2023 | 221 | 1.300 |
Why?
| Ketamine | 2 | 2023 | 84 | 1.290 |
Why?
| Attention | 18 | 2020 | 437 | 1.270 |
Why?
| Chromosomes, Human, Pair 15 | 16 | 2015 | 56 | 1.260 |
Why?
| Gestational Age | 6 | 2024 | 862 | 1.220 |
Why?
| Pursuit, Smooth | 9 | 2007 | 19 | 1.170 |
Why?
| Maternal Exposure | 2 | 2019 | 173 | 1.120 |
Why?
| Pregnancy | 18 | 2024 | 6297 | 1.040 |
Why?
| Acoustic Stimulation | 20 | 2020 | 325 | 0.970 |
Why?
| Mental Disorders | 5 | 2021 | 1007 | 0.970 |
Why?
| Menopause | 4 | 2014 | 303 | 0.970 |
Why?
| Evoked Potentials | 7 | 2020 | 117 | 0.910 |
Why?
| Child Development | 5 | 2024 | 452 | 0.870 |
Why?
| Humans | 125 | 2024 | 128524 | 0.860 |
Why?
| Child Behavior | 2 | 2016 | 236 | 0.860 |
Why?
| Electroconvulsive Therapy | 1 | 2023 | 12 | 0.850 |
Why?
| Dietary Supplements | 5 | 2021 | 529 | 0.840 |
Why?
| Auditory Perception | 8 | 2004 | 111 | 0.810 |
Why?
| Prenatal Care | 4 | 2021 | 271 | 0.810 |
Why?
| Body Temperature Regulation | 4 | 2013 | 99 | 0.790 |
Why?
| Infant, Small for Gestational Age | 1 | 2022 | 84 | 0.780 |
Why?
| Reflex, Startle | 3 | 2014 | 67 | 0.780 |
Why?
| Phosphatidylcholines | 3 | 2018 | 146 | 0.750 |
Why?
| Female | 74 | 2024 | 68127 | 0.740 |
Why?
| Antipsychotic Agents | 8 | 2008 | 194 | 0.740 |
Why?
| Micronutrients | 2 | 2021 | 85 | 0.730 |
Why?
| Infant, Newborn | 10 | 2024 | 5687 | 0.730 |
Why?
| Infant Behavior | 2 | 2020 | 24 | 0.730 |
Why?
| Adult | 55 | 2024 | 35315 | 0.700 |
Why?
| Smoking | 14 | 2013 | 1463 | 0.680 |
Why?
| Neurons | 10 | 2019 | 1448 | 0.670 |
Why?
| Brain Mapping | 6 | 2013 | 568 | 0.660 |
Why?
| Prefrontal Cortex | 3 | 2016 | 297 | 0.650 |
Why?
| Magnetic Resonance Imaging | 13 | 2013 | 3366 | 0.650 |
Why?
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2018 | 61 | 0.640 |
Why?
| Electroencephalography | 11 | 2020 | 393 | 0.640 |
Why?
| Male | 79 | 2024 | 62883 | 0.640 |
Why?
| Hallucinogens | 1 | 2021 | 86 | 0.630 |
Why?
| Editorial Policies | 2 | 2018 | 48 | 0.620 |
Why?
| Endophenotypes | 2 | 2015 | 18 | 0.610 |
Why?
| Saccades | 7 | 2007 | 39 | 0.610 |
Why?
| Perceptual Disorders | 3 | 2005 | 22 | 0.610 |
Why?
| Hydrocortisone | 1 | 2020 | 301 | 0.590 |
Why?
| C-Reactive Protein | 4 | 2022 | 396 | 0.590 |
Why?
| Nootropic Agents | 2 | 2020 | 28 | 0.580 |
Why?
| Premature Birth | 1 | 2021 | 311 | 0.570 |
Why?
| Betacoronavirus | 1 | 2020 | 249 | 0.560 |
Why?
| Problem Behavior | 1 | 2018 | 91 | 0.550 |
Why?
| Depression | 2 | 2023 | 1289 | 0.540 |
Why?
| Primary Prevention | 1 | 2018 | 185 | 0.520 |
Why?
| Image Processing, Computer-Assisted | 6 | 2013 | 732 | 0.520 |
Why?
| Arousal | 6 | 1993 | 150 | 0.510 |
Why?
| Interneurons | 6 | 2001 | 118 | 0.510 |
Why?
| Sleep | 4 | 2014 | 672 | 0.510 |
Why?
| Marijuana Smoking | 1 | 2019 | 239 | 0.510 |
Why?
| Psychological Trauma | 1 | 2016 | 55 | 0.500 |
Why?
| Validation Studies as Topic | 1 | 2015 | 21 | 0.490 |
Why?
| Afferent Pathways | 3 | 2013 | 43 | 0.490 |
Why?
| Cognition Disorders | 3 | 2010 | 496 | 0.480 |
Why?
| Bungarotoxins | 10 | 2008 | 45 | 0.470 |
Why?
| Amygdala | 1 | 2016 | 185 | 0.460 |
Why?
| Genotype | 9 | 2015 | 1831 | 0.460 |
Why?
| Sleep, REM | 3 | 2006 | 32 | 0.450 |
Why?
| Reaction Time | 7 | 2020 | 407 | 0.450 |
Why?
| Aggression | 1 | 2016 | 196 | 0.450 |
Why?
| Teaching | 1 | 2016 | 209 | 0.440 |
Why?
| Cannabis | 1 | 2021 | 435 | 0.440 |
Why?
| Eye Movements | 4 | 2013 | 58 | 0.430 |
Why?
| Sleep Apnea Syndromes | 1 | 2014 | 78 | 0.420 |
Why?
| Phosphorylcholine | 1 | 2013 | 18 | 0.420 |
Why?
| Gyrus Cinguli | 4 | 2006 | 78 | 0.420 |
Why?
| Neural Pathways | 4 | 2010 | 291 | 0.410 |
Why?
| Mothers | 5 | 2021 | 728 | 0.400 |
Why?
| Genetic Linkage | 10 | 2012 | 299 | 0.400 |
Why?
| Neuropsychological Tests | 6 | 2016 | 1003 | 0.400 |
Why?
| Double-Blind Method | 6 | 2016 | 1860 | 0.390 |
Why?
| Ocular Motility Disorders | 2 | 2004 | 26 | 0.380 |
Why?
| Clozapine | 4 | 2004 | 20 | 0.380 |
Why?
| Autism Spectrum Disorder | 1 | 2016 | 378 | 0.370 |
Why?
| Cerebral Cortex | 6 | 2006 | 420 | 0.370 |
Why?
| Emotions | 2 | 2016 | 533 | 0.370 |
Why?
| Middle Aged | 30 | 2016 | 30893 | 0.360 |
Why?
| Cognition | 3 | 2016 | 1107 | 0.350 |
Why?
| Nicotinic Antagonists | 6 | 2008 | 32 | 0.340 |
Why?
| 5-Hydroxytryptophan | 1 | 2009 | 20 | 0.340 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2009 | 43 | 0.330 |
Why?
| Schizotypal Personality Disorder | 2 | 2002 | 10 | 0.330 |
Why?
| Sensation Disorders | 2 | 2007 | 31 | 0.330 |
Why?
| Thalamus | 2 | 2007 | 83 | 0.320 |
Why?
| Infant | 9 | 2021 | 8913 | 0.320 |
Why?
| Dopamine | 7 | 2009 | 285 | 0.320 |
Why?
| Peer Review, Research | 1 | 2009 | 41 | 0.320 |
Why?
| Cocaine-Related Disorders | 2 | 2001 | 108 | 0.320 |
Why?
| Biomedical Research | 1 | 2015 | 646 | 0.320 |
Why?
| Fetus | 4 | 2021 | 758 | 0.320 |
Why?
| Mice, Inbred DBA | 4 | 2008 | 182 | 0.300 |
Why?
| Nitric Oxide Synthase | 2 | 2000 | 232 | 0.300 |
Why?
| Body Temperature | 2 | 2007 | 215 | 0.300 |
Why?
| Substance Withdrawal Syndrome | 2 | 2007 | 171 | 0.300 |
Why?
| Writing | 1 | 2009 | 94 | 0.300 |
Why?
| Child, Preschool | 6 | 2024 | 10373 | 0.300 |
Why?
| Neurons, Afferent | 2 | 1999 | 86 | 0.280 |
Why?
| Sensory Aids | 1 | 2007 | 1 | 0.280 |
Why?
| Miniaturization | 1 | 2007 | 24 | 0.280 |
Why?
| Synaptic Transmission | 6 | 2024 | 260 | 0.280 |
Why?
| Auditory Perceptual Disorders | 3 | 2008 | 9 | 0.280 |
Why?
| Humidity | 1 | 2007 | 50 | 0.280 |
Why?
| Neostriatum | 1 | 2007 | 34 | 0.280 |
Why?
| Equipment and Supplies | 1 | 2007 | 41 | 0.270 |
Why?
| Learning | 2 | 2009 | 390 | 0.270 |
Why?
| Contingent Negative Variation | 2 | 2005 | 7 | 0.270 |
Why?
| Phenotype | 7 | 2018 | 3050 | 0.260 |
Why?
| Child of Impaired Parents | 2 | 1996 | 40 | 0.260 |
Why?
| Pedigree | 8 | 2009 | 485 | 0.260 |
Why?
| Genetic Markers | 7 | 2012 | 339 | 0.260 |
Why?
| Internship and Residency | 1 | 2016 | 1054 | 0.260 |
Why?
| Acetylcholine | 3 | 2002 | 183 | 0.260 |
Why?
| Ganglionic Stimulants | 1 | 2005 | 12 | 0.250 |
Why?
| Biomarkers | 3 | 2015 | 3881 | 0.250 |
Why?
| Animals | 34 | 2021 | 34501 | 0.250 |
Why?
| Adrenergic Uptake Inhibitors | 1 | 2005 | 14 | 0.250 |
Why?
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2005 | 10 | 0.250 |
Why?
| Genetic Predisposition to Disease | 6 | 2013 | 2266 | 0.250 |
Why?
| Child | 9 | 2021 | 20721 | 0.240 |
Why?
| Sensation | 3 | 1991 | 50 | 0.240 |
Why?
| Galvanic Skin Response | 3 | 2013 | 28 | 0.240 |
Why?
| Receptors, Cholinergic | 5 | 2009 | 37 | 0.240 |
Why?
| Reference Values | 8 | 2002 | 780 | 0.230 |
Why?
| Time Perception | 1 | 2005 | 28 | 0.230 |
Why?
| Mice, Inbred C3H | 2 | 2001 | 274 | 0.230 |
Why?
| Sleep Deprivation | 1 | 2006 | 171 | 0.220 |
Why?
| Cross-Over Studies | 3 | 2016 | 513 | 0.220 |
Why?
| Young Adult | 5 | 2022 | 12320 | 0.220 |
Why?
| Bipolar Disorder | 4 | 2007 | 233 | 0.210 |
Why?
| Norepinephrine | 5 | 1992 | 209 | 0.210 |
Why?
| Pyramidal Cells | 3 | 2003 | 71 | 0.210 |
Why?
| Echo-Planar Imaging | 1 | 2002 | 18 | 0.210 |
Why?
| Homovanillic Acid | 5 | 1990 | 10 | 0.200 |
Why?
| Promoter Regions, Genetic | 4 | 2003 | 1199 | 0.200 |
Why?
| Wakefulness | 2 | 2001 | 114 | 0.200 |
Why?
| Rats | 16 | 2002 | 5168 | 0.190 |
Why?
| Linkage Disequilibrium | 2 | 2009 | 256 | 0.190 |
Why?
| Hearing Disorders | 1 | 2001 | 9 | 0.190 |
Why?
| Publishing | 2 | 2016 | 141 | 0.190 |
Why?
| Social Problems | 1 | 2021 | 12 | 0.180 |
Why?
| Vitamin A | 1 | 2021 | 55 | 0.180 |
Why?
| Phencyclidine | 3 | 1992 | 4 | 0.180 |
Why?
| Oxygen | 3 | 2013 | 901 | 0.180 |
Why?
| Dose-Response Relationship, Drug | 5 | 2010 | 1943 | 0.180 |
Why?
| Reward | 1 | 2023 | 239 | 0.180 |
Why?
| Vitamin D | 2 | 2021 | 381 | 0.180 |
Why?
| Frontal Lobe | 3 | 2006 | 151 | 0.180 |
Why?
| Fatty Acids, Omega-3 | 2 | 2021 | 137 | 0.170 |
Why?
| Sweating | 2 | 2013 | 40 | 0.170 |
Why?
| Attention Deficit Disorder with Hyperactivity | 2 | 2004 | 398 | 0.170 |
Why?
| Gene Expression Regulation | 3 | 2015 | 2506 | 0.170 |
Why?
| Vitamins | 1 | 2021 | 172 | 0.170 |
Why?
| Object Attachment | 1 | 2020 | 41 | 0.170 |
Why?
| Chromosome Mapping | 4 | 2009 | 505 | 0.160 |
Why?
| Schizophrenia, Childhood | 1 | 1999 | 3 | 0.160 |
Why?
| Analysis of Variance | 5 | 2008 | 1271 | 0.160 |
Why?
| Pituitary-Adrenal System | 1 | 2020 | 143 | 0.160 |
Why?
| Rats, Sprague-Dawley | 8 | 2002 | 2245 | 0.160 |
Why?
| Disease Models, Animal | 8 | 2009 | 3943 | 0.160 |
Why?
| Bombesin | 1 | 1999 | 12 | 0.160 |
Why?
| Genetic Variation | 3 | 2003 | 934 | 0.160 |
Why?
| Alleles | 5 | 2009 | 845 | 0.160 |
Why?
| Psychiatric Status Rating Scales | 4 | 2005 | 523 | 0.160 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2020 | 176 | 0.160 |
Why?
| Logistic Models | 2 | 2022 | 1975 | 0.150 |
Why?
| RNA, Messenger | 7 | 2006 | 2674 | 0.150 |
Why?
| Maternal Age | 1 | 2019 | 122 | 0.150 |
Why?
| Risk Factors | 10 | 2021 | 9727 | 0.150 |
Why?
| Nutritional Status | 1 | 2021 | 326 | 0.150 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2013 | 52 | 0.150 |
Why?
| Catecholamines | 3 | 2002 | 97 | 0.150 |
Why?
| Stem Cells | 1 | 2002 | 578 | 0.150 |
Why?
| DNA Mutational Analysis | 3 | 2013 | 386 | 0.150 |
Why?
| Psychomotor Performance | 4 | 2005 | 311 | 0.150 |
Why?
| History, 21st Century | 1 | 2018 | 180 | 0.150 |
Why?
| Dentate Gyrus | 1 | 1997 | 29 | 0.140 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2002 | 815 | 0.140 |
Why?
| Irritable Mood | 1 | 2018 | 49 | 0.140 |
Why?
| Adolescent | 12 | 2017 | 20213 | 0.140 |
Why?
| Polymorphism, Single Nucleotide | 4 | 2012 | 2065 | 0.140 |
Why?
| Postmortem Changes | 3 | 2006 | 16 | 0.140 |
Why?
| Urinary Tract Infections | 1 | 2019 | 150 | 0.140 |
Why?
| Family | 4 | 2015 | 642 | 0.140 |
Why?
| Antidepressive Agents, Tricyclic | 1 | 2017 | 30 | 0.140 |
Why?
| Neurocognitive Disorders | 1 | 1996 | 22 | 0.130 |
Why?
| Data Interpretation, Statistical | 1 | 1998 | 335 | 0.130 |
Why?
| Electrophysiology | 6 | 2003 | 205 | 0.130 |
Why?
| Gene Expression | 5 | 2006 | 1462 | 0.130 |
Why?
| Chewing Gum | 2 | 2007 | 9 | 0.130 |
Why?
| Skin Temperature | 2 | 2006 | 31 | 0.130 |
Why?
| Prepulse Inhibition | 1 | 2015 | 9 | 0.130 |
Why?
| Treatment Outcome | 2 | 2023 | 10163 | 0.130 |
Why?
| Benzodiazepines | 2 | 2008 | 129 | 0.120 |
Why?
| Vanilmandelic Acid | 4 | 1990 | 4 | 0.120 |
Why?
| Methoxyhydroxyphenylglycol | 4 | 1990 | 13 | 0.120 |
Why?
| Pneumonia, Viral | 1 | 2020 | 339 | 0.120 |
Why?
| Cerebrovascular Circulation | 2 | 2007 | 221 | 0.120 |
Why?
| Coronavirus Infections | 1 | 2020 | 335 | 0.120 |
Why?
| Nitric Oxide | 1 | 2000 | 886 | 0.120 |
Why?
| Pandemics | 2 | 2021 | 1487 | 0.120 |
Why?
| Cell Differentiation | 1 | 2002 | 1883 | 0.120 |
Why?
| Signal Processing, Computer-Assisted | 2 | 2013 | 143 | 0.120 |
Why?
| Electromyography | 3 | 2005 | 380 | 0.120 |
Why?
| Respiratory Tract Infections | 1 | 2019 | 370 | 0.120 |
Why?
| Postmenopause | 2 | 2007 | 370 | 0.110 |
Why?
| Snoring | 1 | 2014 | 12 | 0.110 |
Why?
| Hot Temperature | 2 | 2007 | 362 | 0.110 |
Why?
| Twins | 1 | 1996 | 249 | 0.110 |
Why?
| Synapsins | 1 | 1993 | 13 | 0.110 |
Why?
| Synaptophysin | 1 | 1993 | 15 | 0.110 |
Why?
| Corpus Striatum | 2 | 1992 | 157 | 0.110 |
Why?
| Clonidine | 1 | 2013 | 27 | 0.110 |
Why?
| Cerebellum | 5 | 2002 | 217 | 0.110 |
Why?
| Sleep Stages | 1 | 1993 | 44 | 0.110 |
Why?
| Polymorphism, Single-Stranded Conformational | 2 | 2003 | 28 | 0.110 |
Why?
| Polymorphism, Genetic | 4 | 2009 | 639 | 0.100 |
Why?
| Brain Tissue Transplantation | 1 | 1992 | 18 | 0.100 |
Why?
| Fetal Tissue Transplantation | 1 | 1992 | 35 | 0.100 |
Why?
| gamma-Aminobutyric Acid | 3 | 2003 | 158 | 0.100 |
Why?
| Mesencephalon | 1 | 1992 | 66 | 0.100 |
Why?
| Genomics | 1 | 2018 | 716 | 0.100 |
Why?
| Perinatal Care | 1 | 2013 | 54 | 0.100 |
Why?
| Zinc | 1 | 1995 | 292 | 0.100 |
Why?
| Estrogen Replacement Therapy | 1 | 2013 | 142 | 0.100 |
Why?
| Parasympathetic Nervous System | 1 | 1992 | 27 | 0.100 |
Why?
| Functional Laterality | 1 | 2013 | 218 | 0.100 |
Why?
| Pregnancy Complications | 2 | 2019 | 488 | 0.100 |
Why?
| Auditory Pathways | 1 | 1992 | 55 | 0.100 |
Why?
| Inflammation | 2 | 2021 | 2664 | 0.100 |
Why?
| Circadian Rhythm | 2 | 2013 | 405 | 0.100 |
Why?
| Heart Rate | 2 | 2007 | 804 | 0.100 |
Why?
| Immunity | 1 | 2013 | 131 | 0.100 |
Why?
| United States | 3 | 2018 | 13876 | 0.100 |
Why?
| Iodine Radioisotopes | 4 | 2001 | 142 | 0.100 |
Why?
| Stress, Psychological | 1 | 2020 | 1058 | 0.100 |
Why?
| Gene Frequency | 2 | 2005 | 504 | 0.100 |
Why?
| Severity of Illness Index | 3 | 2015 | 2736 | 0.100 |
Why?
| Alcoholism | 3 | 2003 | 766 | 0.100 |
Why?
| Memory | 1 | 2013 | 231 | 0.100 |
Why?
| Administration, Oral | 2 | 2005 | 757 | 0.090 |
Why?
| Gene Duplication | 3 | 2015 | 68 | 0.090 |
Why?
| Aged | 10 | 2015 | 21971 | 0.090 |
Why?
| Time Factors | 4 | 2005 | 6503 | 0.090 |
Why?
| Blood Pressure | 3 | 2007 | 1733 | 0.090 |
Why?
| Event-Related Potentials, P300 | 2 | 2003 | 14 | 0.090 |
Why?
| Sleep Apnea, Obstructive | 1 | 2014 | 239 | 0.090 |
Why?
| Case-Control Studies | 4 | 2012 | 3326 | 0.090 |
Why?
| Mice | 8 | 2009 | 16579 | 0.080 |
Why?
| Photic Stimulation | 2 | 2002 | 240 | 0.080 |
Why?
| Genetic Association Studies | 1 | 2012 | 359 | 0.080 |
Why?
| Electrooculography | 2 | 2001 | 12 | 0.080 |
Why?
| Education, Distance | 1 | 2009 | 42 | 0.080 |
Why?
| Alprazolam | 1 | 1988 | 6 | 0.080 |
Why?
| Anxiety Disorders | 1 | 2012 | 347 | 0.080 |
Why?
| Sequence Deletion | 1 | 2009 | 179 | 0.080 |
Why?
| Lorazepam | 1 | 1988 | 24 | 0.080 |
Why?
| Diazepam | 1 | 1988 | 26 | 0.080 |
Why?
| Field Dependence-Independence | 1 | 2008 | 4 | 0.080 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2009 | 87 | 0.080 |
Why?
| Brief Psychiatric Rating Scale | 1 | 2008 | 5 | 0.080 |
Why?
| Rats, Inbred Strains | 6 | 1992 | 356 | 0.070 |
Why?
| Glycols | 1 | 1988 | 6 | 0.070 |
Why?
| Follow-Up Studies | 2 | 2013 | 4898 | 0.070 |
Why?
| Risk | 2 | 2002 | 852 | 0.070 |
Why?
| Evoked Potentials, Somatosensory | 1 | 1988 | 32 | 0.070 |
Why?
| Cross-Sectional Studies | 1 | 2019 | 5040 | 0.070 |
Why?
| Quality Improvement | 1 | 2016 | 1100 | 0.070 |
Why?
| Dihydro-beta-Erythroidine | 2 | 2008 | 5 | 0.070 |
Why?
| Nerve Net | 2 | 2002 | 255 | 0.070 |
Why?
| Genes | 2 | 1998 | 226 | 0.070 |
Why?
| Prospective Studies | 1 | 2019 | 7043 | 0.070 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2013 | 1358 | 0.070 |
Why?
| Parkinson Disease | 1 | 1992 | 451 | 0.070 |
Why?
| Models, Neurological | 2 | 2000 | 235 | 0.070 |
Why?
| Auditory Cortex | 1 | 2007 | 41 | 0.070 |
Why?
| Microsatellite Repeats | 2 | 2012 | 161 | 0.070 |
Why?
| Depressive Disorder | 1 | 1990 | 355 | 0.070 |
Why?
| Diseases in Twins | 1 | 1988 | 176 | 0.070 |
Why?
| Monitoring, Ambulatory | 1 | 2007 | 84 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2008 | 757 | 0.060 |
Why?
| Drug Interactions | 2 | 2008 | 360 | 0.060 |
Why?
| Sensitivity and Specificity | 2 | 2007 | 1820 | 0.060 |
Why?
| Genome | 2 | 2006 | 277 | 0.060 |
Why?
| Telemetry | 1 | 2005 | 40 | 0.060 |
Why?
| Memory, Short-Term | 1 | 2008 | 256 | 0.060 |
Why?
| Cold Temperature | 1 | 2006 | 151 | 0.060 |
Why?
| Internet | 1 | 2009 | 618 | 0.060 |
Why?
| Menstrual Cycle | 1 | 2006 | 124 | 0.060 |
Why?
| Sequence Analysis, DNA | 3 | 2003 | 773 | 0.060 |
Why?
| Quetiapine Fumarate | 1 | 2004 | 22 | 0.060 |
Why?
| Predictive Value of Tests | 2 | 2007 | 1936 | 0.060 |
Why?
| Dibenzothiazepines | 1 | 2004 | 17 | 0.060 |
Why?
| Parietal Lobe | 1 | 2005 | 48 | 0.060 |
Why?
| Visual Pathways | 1 | 2005 | 51 | 0.060 |
Why?
| Statistics as Topic | 1 | 2005 | 304 | 0.060 |
Why?
| Risperidone | 1 | 2004 | 28 | 0.060 |
Why?
| Area Under Curve | 1 | 2005 | 281 | 0.060 |
Why?
| Verbal Behavior | 1 | 2004 | 47 | 0.060 |
Why?
| Dopamine D2 Receptor Antagonists | 1 | 2003 | 5 | 0.060 |
Why?
| Dopamine Antagonists | 1 | 2003 | 21 | 0.050 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 202 | 0.050 |
Why?
| Single-Blind Method | 1 | 2004 | 269 | 0.050 |
Why?
| Visual Fields | 1 | 2004 | 88 | 0.050 |
Why?
| Early Diagnosis | 1 | 2005 | 236 | 0.050 |
Why?
| Mental Recall | 2 | 1996 | 184 | 0.050 |
Why?
| Pain Measurement | 1 | 2005 | 485 | 0.050 |
Why?
| Head | 1 | 2004 | 95 | 0.050 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 236 | 0.050 |
Why?
| Action Potentials | 6 | 1993 | 469 | 0.050 |
Why?
| Age of Onset | 2 | 2007 | 493 | 0.050 |
Why?
| Haloperidol | 1 | 2002 | 36 | 0.050 |
Why?
| Oxygen Consumption | 1 | 2005 | 675 | 0.050 |
Why?
| Nerve Tissue Proteins | 1 | 2006 | 567 | 0.050 |
Why?
| Purkinje Cells | 5 | 1988 | 67 | 0.050 |
Why?
| Chromosomes, Human, Pair 13 | 1 | 2001 | 14 | 0.050 |
Why?
| Visual Cortex | 1 | 2002 | 68 | 0.050 |
Why?
| Radioligand Assay | 1 | 2001 | 46 | 0.050 |
Why?
| Chromosome Disorders | 2 | 1999 | 39 | 0.050 |
Why?
| Exons | 3 | 2015 | 337 | 0.050 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2001 | 16 | 0.050 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2001 | 18 | 0.050 |
Why?
| Lod Score | 1 | 2001 | 66 | 0.050 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2001 | 39 | 0.050 |
Why?
| Sex Characteristics | 1 | 2007 | 727 | 0.050 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2001 | 69 | 0.050 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2001 | 54 | 0.050 |
Why?
| Cloning, Molecular | 2 | 2000 | 522 | 0.050 |
Why?
| Movement | 1 | 2004 | 267 | 0.050 |
Why?
| Binding, Competitive | 1 | 2001 | 199 | 0.050 |
Why?
| Chromosome Aberrations | 2 | 1999 | 147 | 0.050 |
Why?
| Hallucinations | 1 | 2001 | 30 | 0.050 |
Why?
| Cell Count | 1 | 2001 | 314 | 0.050 |
Why?
| Nutritional Requirements | 1 | 2021 | 77 | 0.040 |
Why?
| Fornix, Brain | 1 | 2000 | 6 | 0.040 |
Why?
| Denervation | 1 | 2000 | 20 | 0.040 |
Why?
| Family Health | 1 | 2001 | 194 | 0.040 |
Why?
| Lymphocytes | 1 | 2002 | 366 | 0.040 |
Why?
| NG-Nitroarginine Methyl Ester | 1 | 2000 | 46 | 0.040 |
Why?
| Point Mutation | 2 | 1999 | 224 | 0.040 |
Why?
| Multifactorial Inheritance | 1 | 2001 | 149 | 0.040 |
Why?
| Animals, Newborn | 1 | 2002 | 805 | 0.040 |
Why?
| Blotting, Northern | 2 | 2005 | 199 | 0.040 |
Why?
| Blotting, Western | 3 | 2005 | 1168 | 0.040 |
Why?
| Algorithms | 1 | 2007 | 1616 | 0.040 |
Why?
| Binding Sites | 1 | 2002 | 1239 | 0.040 |
Why?
| Cocaine | 1 | 2001 | 151 | 0.040 |
Why?
| Fathers | 1 | 1999 | 48 | 0.040 |
Why?
| Genetic Testing | 1 | 2001 | 427 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 937 | 0.040 |
Why?
| Chromatography, High Pressure Liquid | 3 | 1989 | 475 | 0.040 |
Why?
| Developmental Disabilities | 1 | 2021 | 254 | 0.040 |
Why?
| Self Medication | 1 | 1998 | 10 | 0.040 |
Why?
| Cell Movement | 1 | 2002 | 937 | 0.040 |
Why?
| Cholinergic Agents | 1 | 1998 | 15 | 0.040 |
Why?
| Genetics, Population | 1 | 1999 | 200 | 0.040 |
Why?
| Heterozygote | 1 | 1998 | 266 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 1998 | 123 | 0.040 |
Why?
| Electric Conductivity | 2 | 1998 | 95 | 0.040 |
Why?
| Immunohistochemistry | 1 | 2001 | 1669 | 0.040 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 1997 | 4 | 0.030 |
Why?
| Conditioning, Classical | 2 | 2008 | 97 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 2000 | 538 | 0.030 |
Why?
| Parents | 2 | 2015 | 1306 | 0.030 |
Why?
| Memory Disorders | 1 | 1998 | 158 | 0.030 |
Why?
| Age Factors | 2 | 2006 | 3117 | 0.030 |
Why?
| Base Sequence | 3 | 2009 | 2134 | 0.030 |
Why?
| In Situ Hybridization | 2 | 2013 | 292 | 0.030 |
Why?
| Sensory Thresholds | 1 | 1996 | 32 | 0.030 |
Why?
| Motor Activity | 2 | 1992 | 667 | 0.030 |
Why?
| Nerve Fibers | 1 | 1995 | 87 | 0.030 |
Why?
| Receptors, Glutamate | 1 | 1995 | 22 | 0.030 |
Why?
| Nerve Growth Factors | 1 | 1995 | 73 | 0.030 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 323 | 0.030 |
Why?
| Siblings | 1 | 2015 | 215 | 0.030 |
Why?
| Placenta | 1 | 2021 | 714 | 0.030 |
Why?
| Surveys and Questionnaires | 1 | 2007 | 5346 | 0.030 |
Why?
| Aging | 2 | 1999 | 1770 | 0.030 |
Why?
| Dyskinesia, Drug-Induced | 1 | 1994 | 15 | 0.030 |
Why?
| Cholinergic Fibers | 1 | 1993 | 17 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 1995 | 1019 | 0.030 |
Why?
| Orientation | 1 | 1994 | 43 | 0.030 |
Why?
| Horseradish Peroxidase | 1 | 1993 | 28 | 0.030 |
Why?
| Neuromuscular Junction | 1 | 1994 | 57 | 0.030 |
Why?
| Chronic Disease | 1 | 1999 | 1701 | 0.030 |
Why?
| Genetic Engineering | 1 | 1994 | 88 | 0.030 |
Why?
| Axonal Transport | 1 | 1993 | 25 | 0.030 |
Why?
| Synaptic Vesicles | 1 | 1993 | 43 | 0.030 |
Why?
| Temporal Lobe | 1 | 1993 | 85 | 0.030 |
Why?
| Peptides | 1 | 1999 | 909 | 0.030 |
Why?
| Tissue Banks | 1 | 2013 | 15 | 0.030 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2013 | 47 | 0.030 |
Why?
| DNA Probes | 1 | 2013 | 61 | 0.030 |
Why?
| Habituation, Psychophysiologic | 1 | 1993 | 53 | 0.030 |
Why?
| Nomifensine | 1 | 1992 | 4 | 0.030 |
Why?
| HLA-A Antigens | 1 | 2013 | 53 | 0.030 |
Why?
| Gene Expression Profiling | 2 | 2013 | 1687 | 0.030 |
Why?
| Poly A | 1 | 1993 | 48 | 0.030 |
Why?
| Genes, MHC Class I | 1 | 2013 | 33 | 0.030 |
Why?
| Receptors, sigma | 1 | 1992 | 2 | 0.030 |
Why?
| Biogenic Monoamines | 1 | 1992 | 15 | 0.030 |
Why?
| Benzylamines | 1 | 1992 | 41 | 0.030 |
Why?
| Sympathomimetics | 1 | 1992 | 21 | 0.030 |
Why?
| Tomography, Emission-Computed | 1 | 1992 | 66 | 0.030 |
Why?
| Tubocurarine | 1 | 1992 | 4 | 0.030 |
Why?
| Levodopa | 1 | 1992 | 29 | 0.030 |
Why?
| N-Methylaspartate | 1 | 1992 | 36 | 0.030 |
Why?
| Mecamylamine | 1 | 1992 | 9 | 0.030 |
Why?
| Muscles | 1 | 1994 | 323 | 0.030 |
Why?
| Parasympatholytics | 1 | 1992 | 13 | 0.030 |
Why?
| Injections, Intraventricular | 1 | 1992 | 53 | 0.030 |
Why?
| Microelectrodes | 1 | 1992 | 41 | 0.020 |
Why?
| Nervous System | 1 | 1992 | 65 | 0.020 |
Why?
| Aged, 80 and over | 2 | 2002 | 7040 | 0.020 |
Why?
| Physical Chromosome Mapping | 1 | 2012 | 17 | 0.020 |
Why?
| Temperature | 1 | 1995 | 625 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 326 | 0.020 |
Why?
| Genotyping Techniques | 1 | 2012 | 72 | 0.020 |
Why?
| DNA Replication | 1 | 1993 | 224 | 0.020 |
Why?
| Transcription, Genetic | 1 | 1997 | 1398 | 0.020 |
Why?
| RNA | 2 | 2013 | 881 | 0.020 |
Why?
| Recombinant Proteins | 1 | 1994 | 1284 | 0.020 |
Why?
| Protein Biosynthesis | 1 | 1993 | 397 | 0.020 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 1994 | 375 | 0.020 |
Why?
| Molecular Sequence Data | 3 | 2003 | 2818 | 0.020 |
Why?
| Introns | 2 | 2003 | 245 | 0.020 |
Why?
| Risk Assessment | 1 | 1999 | 3256 | 0.020 |
Why?
| Saccharomyces cerevisiae | 1 | 1994 | 522 | 0.020 |
Why?
| Adenylate Cyclase Toxin | 1 | 1989 | 8 | 0.020 |
Why?
| Virulence Factors, Bordetella | 1 | 1989 | 19 | 0.020 |
Why?
| Receptors, Dopamine | 1 | 1989 | 16 | 0.020 |
Why?
| Pertussis Toxin | 1 | 1989 | 26 | 0.020 |
Why?
| Blotting, Southern | 1 | 2009 | 68 | 0.020 |
Why?
| Autoanalysis | 1 | 1989 | 6 | 0.020 |
Why?
| Adenylyl Cyclases | 1 | 1989 | 82 | 0.020 |
Why?
| Electrochemistry | 1 | 1989 | 80 | 0.020 |
Why?
| Odds Ratio | 1 | 2012 | 1022 | 0.020 |
Why?
| Yohimbine | 1 | 1988 | 9 | 0.020 |
Why?
| Dioxins | 1 | 1988 | 5 | 0.020 |
Why?
| Dioxanes | 1 | 1988 | 6 | 0.020 |
Why?
| Cell Line | 2 | 2009 | 2731 | 0.020 |
Why?
| GTP-Binding Proteins | 1 | 1989 | 155 | 0.020 |
Why?
| Gene Dosage | 1 | 2009 | 142 | 0.020 |
Why?
| Receptors, Adrenergic | 1 | 1988 | 34 | 0.020 |
Why?
| Tyramine | 1 | 1988 | 8 | 0.020 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2009 | 313 | 0.020 |
Why?
| Pulse | 1 | 1988 | 27 | 0.020 |
Why?
| Saliva | 1 | 1989 | 205 | 0.020 |
Why?
| Fluphenazine | 1 | 1987 | 5 | 0.020 |
Why?
| Tobacco Use Disorder | 1 | 2010 | 239 | 0.020 |
Why?
| Audiometry, Evoked Response | 1 | 1987 | 11 | 0.020 |
Why?
| Stereoisomerism | 1 | 1987 | 92 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2008 | 423 | 0.020 |
Why?
| Autoradiography | 2 | 1997 | 74 | 0.020 |
Why?
| Tyrosine | 1 | 1988 | 216 | 0.020 |
Why?
| Mutation | 2 | 2015 | 3692 | 0.020 |
Why?
| Task Performance and Analysis | 1 | 2007 | 173 | 0.020 |
Why?
| Depressive Disorder, Major | 1 | 2010 | 347 | 0.020 |
Why?
| Suicide | 1 | 1993 | 586 | 0.020 |
Why?
| ROC Curve | 1 | 2007 | 501 | 0.020 |
Why?
| Transcription Factors | 1 | 1994 | 1631 | 0.020 |
Why?
| Hypoxia-Ischemia, Brain | 1 | 2006 | 31 | 0.020 |
Why?
| alpha Catenin | 1 | 2005 | 12 | 0.020 |
Why?
| Patient Selection | 1 | 2009 | 661 | 0.020 |
Why?
| Microarray Analysis | 1 | 2005 | 121 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2006 | 538 | 0.010 |
Why?
| Nervous System Diseases | 1 | 1987 | 251 | 0.010 |
Why?
| Diagnosis, Differential | 1 | 2007 | 1416 | 0.010 |
Why?
| Fourier Analysis | 1 | 2002 | 39 | 0.010 |
Why?
| Genome-Wide Association Study | 1 | 2009 | 1337 | 0.010 |
Why?
| Artifacts | 1 | 2002 | 121 | 0.010 |
Why?
| Sex Factors | 1 | 2006 | 1949 | 0.010 |
Why?
| Diet | 1 | 1988 | 1200 | 0.010 |
Why?
| Contig Mapping | 1 | 1998 | 10 | 0.010 |
Why?
| Genes, Duplicate | 1 | 1998 | 4 | 0.010 |
Why?
| Restriction Mapping | 1 | 1998 | 74 | 0.010 |
Why?
| Receptors, Presynaptic | 1 | 1998 | 7 | 0.010 |
Why?
| Models, Biological | 1 | 2005 | 1693 | 0.010 |
Why?
| Macaca radiata | 1 | 1997 | 15 | 0.010 |
Why?
| Autopsy | 1 | 1997 | 92 | 0.010 |
Why?
| Organ Specificity | 1 | 1997 | 291 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 1996 | 402 | 0.010 |
Why?
| Species Specificity | 1 | 1996 | 567 | 0.010 |
Why?
| Cell Adhesion Molecules, Neuronal | 1 | 1995 | 39 | 0.010 |
Why?
| Gene Amplification | 1 | 1995 | 103 | 0.010 |
Why?
| Isomerases | 1 | 1994 | 8 | 0.010 |
Why?
| tau Proteins | 1 | 1995 | 78 | 0.010 |
Why?
| Protein Disulfide-Isomerases | 1 | 1994 | 8 | 0.010 |
Why?
| Genes, Fungal | 1 | 1994 | 51 | 0.010 |
Why?
| DNA Primers | 1 | 1995 | 510 | 0.010 |
Why?
| Endopeptidases | 1 | 1994 | 83 | 0.010 |
Why?
| Molecular Biology | 1 | 1994 | 55 | 0.010 |
Why?
| Glycosylation | 1 | 1994 | 146 | 0.010 |
Why?
| Cadaver | 1 | 1995 | 330 | 0.010 |
Why?
| Fungal Proteins | 1 | 1994 | 129 | 0.010 |
Why?
| Genetic Vectors | 1 | 1994 | 311 | 0.010 |
Why?
| DNA | 1 | 1998 | 1392 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 1994 | 2041 | 0.010 |
Why?
| Idazoxan | 1 | 1988 | 1 | 0.000 |
Why?
| Phentolamine | 1 | 1988 | 14 | 0.000 |
Why?
| Receptors, Adrenergic, alpha | 1 | 1988 | 25 | 0.000 |
Why?
| Rats, Inbred F344 | 1 | 1988 | 251 | 0.000 |
Why?
| Desipramine | 1 | 1988 | 10 | 0.000 |
Why?
| Receptors, Adrenergic, beta | 1 | 1988 | 126 | 0.000 |
Why?
| Magnesium | 1 | 1987 | 151 | 0.000 |
Why?
| DNA-Binding Proteins | 1 | 1994 | 1415 | 0.000 |
Why?
|
|
Freedman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|